Your email has been successfully added to our mailing list.

×
0.131147540983606 0.147540983606557 0.14207650273224 0.098360655737705 0.224043715846995 0.153005464480874 0.147540983606557 0.139344262295082
Stock impact report

Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111

Auris Medical Holding AG (EARS) 
Last auris medical holding ag earnings: 8/10 06:31 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aurismedical.com
Company Research Source: GlobeNewswire
Design for single pivotal phase 3 trial validated by European Medicines Agency  Regulatory pathway towards European market approval mapped out Strategy update scheduled together with earnings release for May 15, 2018 Zug, Switzerland, May 7, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, announced today that the Company has received positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the development plan and regulatory pathway for AM-111, its investigational treatment for acute inner ear hearing loss. The Scientific Advice (Protocol Assistance) had been requested by the Company following the results of the HEALOS phase 3 trial. The results showed, based on a post-hoc analysis, a clinically meaningful and nominally significant improvement in hearing for the AM-111 Show less Read more
Impact Snapshot
Event Time:
EARS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for EARS alerts
Opt-in for
EARS alerts

from News Quantified
Opt-in for
EARS alerts

from News Quantified